Lipolytic effects of beta1, beta2 and beta3-adrenergic agonists in isolated human fat cells from omental and retroperitoneal adipose tissues. 1995

M P Portillo, and A M Rocandio, and M A Garcia-Calonge, and E Diaz, and E Campo, and C Martinez-Blazquez, and J Errasti, and A S del Barrio
Departamento de Nutricion y Bromatologia, Universidad del Pais Vasco, Vitoria, Spain.

The presence of beta1- and beta2-adrenoceptors has been clearly established in human fat cells. There is some controversy about the presence and function of beta3-adrenoceptors. It is well established that there are marked regional variations in catecholamine-induced lipolysis. In this work the possibility that a beta3-adrenoceptor plays a significant role in the control of lipid mobilization is studied and also its importance in comparison to beta1- and beta2-adrenoceptors in isolated human fat cells, is evaluated, by measuring the in vitro lipolysis induced by dobutamine, salbutamol, metaproterenol, BRL 37344 and CGP 12177A. Human adipocytes from omental and retroperitoneal fat deposits exhibited an "atypical" beta-adrenergic response but, given the small lipolytic effect initiated by BRL 37344 and CGP 12177A, they are probably poorly equipped in functional beta3-adrenoceptors.

UI MeSH Term Description Entries
D008066 Lipolysis The metabolic process of breaking down LIPIDS to release FREE FATTY ACIDS, the major oxidative fuel for the body. Lipolysis may involve dietary lipids in the DIGESTIVE TRACT, circulating lipids in the BLOOD, and stored lipids in the ADIPOSE TISSUE or the LIVER. A number of enzymes are involved in such lipid hydrolysis, such as LIPASE and LIPOPROTEIN LIPASE from various tissues. Lipolyses
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009852 Omentum A double-layered fold of peritoneum that attaches the STOMACH to other organs in the ABDOMINAL CAVITY. Omentums
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D000318 Adrenergic beta-Agonists Drugs that selectively bind to and activate beta-adrenergic receptors. Adrenergic beta-Receptor Agonists,beta-Adrenergic Agonists,beta-Adrenergic Receptor Agonists,Adrenergic beta-Agonist,Adrenergic beta-Receptor Agonist,Betamimetics,Receptor Agonists, beta-Adrenergic,Receptors Agonists, Adrenergic beta,beta-Adrenergic Agonist,beta-Adrenergic Receptor Agonist,Adrenergic beta Agonist,Adrenergic beta Agonists,Adrenergic beta Receptor Agonist,Adrenergic beta Receptor Agonists,Agonist, Adrenergic beta-Receptor,Agonist, beta-Adrenergic,Agonist, beta-Adrenergic Receptor,Agonists, Adrenergic beta-Receptor,Agonists, beta-Adrenergic,Agonists, beta-Adrenergic Receptor,Receptor Agonist, beta-Adrenergic,Receptor Agonists, beta Adrenergic,beta Adrenergic Agonist,beta Adrenergic Agonists,beta Adrenergic Receptor Agonist,beta Adrenergic Receptor Agonists,beta-Agonist, Adrenergic,beta-Agonists, Adrenergic,beta-Receptor Agonist, Adrenergic,beta-Receptor Agonists, Adrenergic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

M P Portillo, and A M Rocandio, and M A Garcia-Calonge, and E Diaz, and E Campo, and C Martinez-Blazquez, and J Errasti, and A S del Barrio
March 1999, Journal of animal science,
M P Portillo, and A M Rocandio, and M A Garcia-Calonge, and E Diaz, and E Campo, and C Martinez-Blazquez, and J Errasti, and A S del Barrio
July 2010, British journal of pharmacology,
M P Portillo, and A M Rocandio, and M A Garcia-Calonge, and E Diaz, and E Campo, and C Martinez-Blazquez, and J Errasti, and A S del Barrio
January 2001, The Journal of endocrinology,
M P Portillo, and A M Rocandio, and M A Garcia-Calonge, and E Diaz, and E Campo, and C Martinez-Blazquez, and J Errasti, and A S del Barrio
February 2000, Molecular pharmacology,
M P Portillo, and A M Rocandio, and M A Garcia-Calonge, and E Diaz, and E Campo, and C Martinez-Blazquez, and J Errasti, and A S del Barrio
May 2001, Molecular and cellular biochemistry,
M P Portillo, and A M Rocandio, and M A Garcia-Calonge, and E Diaz, and E Campo, and C Martinez-Blazquez, and J Errasti, and A S del Barrio
January 1978, European journal of pharmacology,
M P Portillo, and A M Rocandio, and M A Garcia-Calonge, and E Diaz, and E Campo, and C Martinez-Blazquez, and J Errasti, and A S del Barrio
October 2009, Cell biochemistry and function,
M P Portillo, and A M Rocandio, and M A Garcia-Calonge, and E Diaz, and E Campo, and C Martinez-Blazquez, and J Errasti, and A S del Barrio
June 2004, Medicine and science in sports and exercise,
M P Portillo, and A M Rocandio, and M A Garcia-Calonge, and E Diaz, and E Campo, and C Martinez-Blazquez, and J Errasti, and A S del Barrio
October 1998, American journal of obstetrics and gynecology,
M P Portillo, and A M Rocandio, and M A Garcia-Calonge, and E Diaz, and E Campo, and C Martinez-Blazquez, and J Errasti, and A S del Barrio
January 1998, Life sciences,
Copied contents to your clipboard!